Loss of Taste as an Initial Symptom of a “Facial Diplegia and Paresthesia” Variant of Guillain-Barré Syndrome

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Loss of taste is a relatively common symptom of coronavirus disease 2019 (COVID-19) and has also been considered a rare Guillain-Barré syndrome (GBS) symptom. We herein report a case of a facial diplegia and paresthesia (FDP) variant of GBS that initially presented as a loss of taste occurring two weeks after COVID-19 mRNA vaccination. The patient recovered completely after intravenous immunoglobulin therapy. Clinicians should consider the possibility of post-vaccination FDP manifesting as facial palsy and should be aware that GBS, including the FDP variant, can initially present as an isolated loss of taste.

Cite

CITATION STYLE

APA

Hiraga, A., Muto, M., & Kuwabara, S. (2022). Loss of Taste as an Initial Symptom of a “Facial Diplegia and Paresthesia” Variant of Guillain-Barré Syndrome. Internal Medicine, 61(19), 2957–2959. https://doi.org/10.2169/internalmedicine.9781-22

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free